Achilles Therapeutics plc - American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share (ACHL)

Historical Holders from Q1 2021 to Q3 2025

Symbol
ACHL
Type / Class
Equity / American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share
Shares outstanding
41,123,390
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
5,286
Holdings value
$7,822
Number of holders
2
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Achilles Therapeutics plc - American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share (ACHL)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BML Investment Partners, L.P. 9.97% $6,066,773 4,100,002 BML Investment Partners, L.P. 31 Dec 2024

Institutional Holders of Achilles Therapeutics plc - American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share (ACHL)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 5,286 $7,822 $1.48 2
2025 Q2 5,286 $7,822 -$72,397 $1.48 2
2025 Q1 54,405 $80,219 -$27,599,327 $1.48 5
2024 Q4 24,297,978 $27,722,908 -$94,040 $1.14 21
2024 Q3 24,338,965 $24,820,801 +$1,848,962 $1.02 22
2024 Q2 22,188,649 $18,079,945 -$1,749,977 $0.815 26
2024 Q1 23,510,455 $29,386,379 +$2,669,497 $1.25 31
2023 Q4 21,782,170 $19,366,883 -$363,258 $0.889 19
2023 Q3 19,691,035 $17,916,533 -$91,084 $0.9099 16
2023 Q2 19,786,405 $18,702,369 -$522,912 $0.9452 16
2023 Q1 20,235,741 $19,376,340 -$1,268,448 $0.9575 16
2022 Q4 21,665,748 $19,499,479 -$7,998,675 $0.9 21
2022 Q3 27,268,502 $61,628,035 +$234,013 $2.26 25
2022 Q2 27,134,733 $68,384,811 +$1,415,523 $2.52 23
2022 Q1 15,481,857 $45,523,508 -$4,266,786 $2.94 21
2021 Q4 27,433,563 $137,451,000 -$12,949,488 $5.01 28
2021 Q3 17,597,059 $137,080,000 -$11,368,450 $7.79 19
2021 Q2 18,784,784 $183,902,000 +$18,216,534 $9.79 29
2021 Q1 16,807,348 $278,162,000 +$278,162,000 $16.55 29